Literature DB >> 27918740

Inflammatory papillary hyperplasia: A systematic review.

P Gual-Vaqués1, E Jané-Salas, S Egido-Moreno, R Ayuso-Montero, A Marí-Roig, J López-López.   

Abstract

INTRODUCTION: Inflammatory papillary hyperplasia (IPH) is a benign lesion of the palatal mucosa. It is usually found in denture-wearers but also has been reported in patients without a history of use of a maxillary prosthesis use.
OBJECTIVES: The aim of this study is to review the literature to assess the prevalence of denture stomatitis and inflammatory papillary hyperplasia and the etiological factors associated.
MATERIAL AND METHODS: A search was carried out in PubMed (January 2005 to October 2015) with the key words "inflammatory papillary hyperplasia", "denture stomatitis", "granular stomatitis" and "Newton's type III" The inclusion criteria were studies including at least a sample of 50 apparently healthy patients, articles published from 2005 to 2015 written in English. The exclusion criteria were reviews and non-human studies.
RESULTS: Out of the 190 studies obtained initially from the search 16 articles were selected to be included in our systematic review. The prevalence of denture stomatitis was 29.56% and 4.44% for IPH. We found 5 cases of denture stomatitis among non-denture-wearer individuals. All IPH cases were associated with the use of prosthesis. Smoking and continued use of ill-fitting dentures turned out to be the most frequent risk factors for developing IPH.
CONCLUSIONS: IPH is a rare oral lesion and its pathogenesis still remains unclear. Its presentation among non-denture-wearers is extremely unusual.

Entities:  

Mesh:

Year:  2017        PMID: 27918740      PMCID: PMC5217495          DOI: 10.4317/medoral.21405

Source DB:  PubMed          Journal:  Med Oral Patol Oral Cir Bucal        ISSN: 1698-4447


Introduction

Inflammatory papillary hyperplasia (IPH) is a benign lesion of the oral mucosa which is characterized by the growth of one or more nodular lesions, measuring about 2mm or less (Fig. 1). The lesion almost exclusively involves the hard palate (1-4). Nevertheless, in rare instances, it also has been seen on the mandible (5). The lesion is mostly asymptomatic and the color of the mucosa may vary from pink to red (1-5).
Figure 1

Inflammatory papillary hyperplasia. A case showing some injuries (marked by arrow) located under the framework.

Inflammatory papillary hyperplasia. A case showing some injuries (marked by arrow) located under the framework. In general, IPH is associated with the use of removable upper dentures although it also has been found in dentulous patients with no history of a dental prosthesis (1,5). The lesion can be classified in the third type of denture stomatitis (Newton’s classification, 1962) when it is related to removable prosthesis (6). In a study carried out by Ettinger (7) with a sample of 700 subjects who were upper denture wearers, prevalence of IPH was found to be around 14%. Histopathologically, the lesion has been described as papillary projections covered by stratified squamous epithelium with or without chronic inflammation (2) (Fig. 2). Although historically some authors believed the lesions had a premalignant component (1,5), the current predominant belief based on diverse and extensive histologic samples is that the lesion has a predominantly inflammatory nature (2,4).
Figure 2

Epithelial hyperplasia with inflammation and fibrosis in Hematoxylin-Eosin at 200x magnification.

Epithelial hyperplasia with inflammation and fibrosis in Hematoxylin-Eosin at 200x magnification. The pathogenesis is unclear. The following have been suggested as potential etiological factors: ill-fitting dentures, continuous day and night denture use, poor oral hygiene, sensitivity to denture liners, tobacco, age related changes and some systemic conditions (1-4). IPH is also associated with the colonization of Candida caused by poor oral hygiene (4,5). However, Candida is not indispensable for the development of denture stomatitis (8-10). The treatment of IPH varies widely among clinicians. The type of treatment rendered is related to the severity of the condition and the clinical presentation (4). When the clinical presentation is aggressive and large papillary lesions are present, clinicians have recommended laser (11), electrosurgery (12) or cryotherapy (13). Small localized lesions have been typically treated with mouthrinses. Orenstein & Taylor (4) use clorhexidine mouthrinse at 0.12% and Salonen et al. (14) prescribe antifungal mouthrinse or gels. The objective of the present study was to evaluate the prevalence of denture stomatitis and inflammatory papillary hyperplasia in the past 10 years and the etiological factors associated with them.

Material and Methods

In this systematic review, a search was carried out in MEDLINE (PubMed) database (January 2005 to October 2015) with the key words “inflammatory papillary hyperplasia”, “denture stomatitis”, “granular stomatitis” and “Newton’s type III”. The terms were merged using the Boolean operator “OR”. The inclusion criteria were studies including at least a sample of 50 apparently healthy patients, articles published from 2005 to 2015 written in English. The exclusion criteria were reviews and nonhuman studies. The articles were selected firstly by reading the titles and abstracts of the citations found in the bibliography to identify the most relevant studies and then, by means of reading the full-text article.

Results

Out of the 190 studies obtained initially from the search 171 articles were excluded after applying the inclusion and exclusion criteria. Thus, the complete text of 19 studies was analyzed. Two of these 19 articles were excluded due to the lack of direct relationship with the subject and another one was removed because the sample included clinical cases from the year 1993 (Fig. 3).
Figure 3

Flow of articles through the systematic review.

Flow of articles through the systematic review. The 16 articles were stratified according to their level of evidence, using Jadad scale (15). All of them were classified with a level 2 scientific evidence ( Table 1).
Table 1

Quality assessment of the articles included in the review using Jadad scale (15).

The studies included analyzed, among other parameters, the prevalence of denture stomatitis in different population groups. Thus, with a total sample of 30.797 patients with a mean age ≥60 years, the prevalence of denture stomatitis for our review was found to be 29.56% ( Table 2).
Table 2

Summary of the 16 articles reviewed.

In the sample analyzed, all cases of papillary inflammatory hyperplasia (109 cases) occur in denture wearers, with a prevalence of 4.43%. Freitas et al. (16) reported 5 cases of denture stomatitis in non-denture-wearing patients. Nevertheless, the authors did not specify the type of denture stomatitis according to Newton’s classification (6). So, we can conclude that the prevalence of IPH in non- denture-wearing patients for our sample is 0% ( Table 3).
Table 3

Prevalence of IPH.

Discussion

The prevalence of denture stomatitis and the associated risk factors differ in various studies, mainly because of differences in research methodology (age of the study group, dental status of the study group, dental school patients or community population, institutionalized or non-institutionalized patients, different method of assessment of various factors and subjectivity of classification) (17). In general, the prevalence rate of denture stomatitis is reported within the range of 20-67% (18), in accordance with the present review with a prevalence of 29.56%. The majority of the studies analyzed (16-24) report different rates of prevalence, all within this range. On the other hand (25-28), reported rates of prevalence of denture stomatitis lower than 6%. Mathew et al. (26), with a low prevalence of 0.84%, attributed the result to the low number of denture wearing subjects in the study group (45 out of 1190). According to Taiwo et al. (27), this observation is consistent with the finding of minimal tooth loss and edentulism in the study group. Ferreira et al. (29) and Da Silva et al. (30) found a strong correlation between denture stomatitis and poor hygiene in the use of prostheses. This is in compliance with previous publications (31-34). Other factors, such as the continuous wearing of the dentures (16,17,19,20,25,26,28), and the integrity and adaptation of the prosthesis (16,18,19,28,35); have also been considered statistically significant factors. Dundar et al. (25) found a correlation between diabetes mellitus and denture stomatitis. On the other hand, Kossioni (17) observed that denture stomatitis was more prevalent among smokers, even though the correlation was statistically insignificant. The study of the prevalence of inflammatory papillary hyperplasia or type III denture stomatitis is complex because to the majority of publications fail to distinguish between different types of denture stomatitis, in accordance with Newton’s classification (6). In fact, in the literature reviewed we have not been able to find any article studying exclusively the IPH prevalence. The reality is that IPH was of great interest in the 60’s and 70’s when it was believed that the lesion had a premalignant component (1,5). This led to research and several studies were carried out in order to determine the cause and prevalence of the lesion [Ettinger, 1975 (7); Lambson, 1967 (36); Waite, 1961 (37)]. Out of the 16 articles reviewed only 9 mention inflammatory papillary hyperplasia. In the year 1975, Ettinger (7) assessed the prevalence of IPH in a sample of 700 subjects, obtaining a considerable prevalence of 13.9%. This result is in contrast with the occurrence rate found in our review (4.43%). With regards to etiological factors, most of the literature suggests that there are several factors associated with IPH. Atashrazm et al. (24) reported 31 cases of IPH in a group of 201 complete denture wearers. The authors mention the presence of vacuum suction in all maxillary dentures and suggest a possible relationship with IPH. With a prevalence of 2.29%, Dos Santos et al. (20) observed that patients with IPH were significantly most likely to be 70 years old or older, smokers and live in rural areas. In addition, the mean denture plaque score of those with IPH was higher. Al-Dwairi (38) also established a close relationship between smoking and IPH, suggesting that aggressive forms of granular stomatitis are associated with a daily consumption of 25 cigarettes. In compliance with previous studies (2,5), Canger et al. (19) concluded that the most significant risk factor for IPH is wearing ill-fitting dentures for more than 10 years. In addition, and in accordance to Coelho et al.(39), gender was also found to be another significant factor. The high prevalence of IPH within the females can be attributed to the fact that females live longer than men, more women wear dentures (and for longer periods) than men and also due to postmenopausal changes that make the oral mucosa more susceptible to hyperplasic changes. In compliance with Fisher et al. (2), Kossioni (17) noted that the frequency of denture cleaning was significantly related to IPH. Other factors such as age, gender and tobacco were not found to be significant for any type of denture stomatitis. In the literature reviewed, we have found only 2 cases of IPH in non-denture-wearing patients. The first case, published in 1976, refers to a dentulous patient who had never worn dental prosthesis. On the oral examination, multiple papules could be seen on the palatal mucosa. The authors concluded that there was no apparent reason for occurrence of IPH in this individual (5). The second case report presented a 10 year old female who had a single nodule on the hard palate. The oral examination revealed poor oral hygiene conditions and mouth breathing. The child had no history of appliance therapy with either a metal or acrylic base. An excisional biopsy of the lesion was done and the provisional diagnosis of IPH was thus confirmed. In this case, the authors attributed the IPH to the poor oral hygiene and the fact the patient was a mouth breather (4). Conclusions In compliance with the literature reviewed, the prevalence of denture stomatitis varies from 20-67%. Poor oral hygiene and the continuous use of dentures were found to be the most significant risk factors for developing denture stomatitis. IPH is a rare benign lesion and its pathogenesis remains unclear. The predisposing factors most widely described are continuous day and night ill-fitting denture use, poor oral condition and smoking. The presence of IPH among non-denture-wearing patients is extremely unusual although is more likely to occur in patients with poor oral hygiene, smokers and/or mouth breathers. In short, we would like to emphasize that a maxillary denture may not be the exclusive etiology for the appearance of IPH.
  38 in total

1.  Inflammatory papillary hyperplasia of the palate: quantitative analysis of candida albicans and its negative correlation with microscopic and demographic aspects.

Authors:  Maria Carolina Vaz Goulart; Vanessa Soares Lara
Journal:  Int J Prosthodont       Date:  2011 May-Jun       Impact factor: 1.681

Review 2.  The association of denture stomatitis and partial removable dental prostheses: a systematic review.

Authors:  Elham Emami; Hanan Taraf; Pierre de Grandmont; Gilles Gauthier; Louis de Koninck; Claude Lamarche; Raphael F de Souza
Journal:  Int J Prosthodont       Date:  2012 Mar-Apr       Impact factor: 1.681

3.  Oral mucosal alterations among the institutionalized elderly in Brazil.

Authors:  Raquel Conceição Ferreira; Cláudia Silami de Magalhães; Allyson Nogueira Moreira
Journal:  Braz Oral Res       Date:  2010 Jul-Sep

4.  Palatal papillary hyperplasia.

Authors:  G O Lambson; R R Anderson
Journal:  J Prosthet Dent       Date:  1967-12       Impact factor: 3.426

5.  The role of Candida in inflammatory papillary hyperplasia of the palate.

Authors:  A Poulopoulos; M Belazi; A Epivatianos; A Velegraki; D Antoniades
Journal:  J Oral Rehabil       Date:  2007-09       Impact factor: 3.837

6.  A comparison of healing and pain following excision of inflammatory papillary hyperplasia with electrosurgery and blade-loop knives in human patients.

Authors:  S A Rathofer; F M Gardner; S G Vermilyea
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1985-02

7.  Prevalence of oral soft tissue lesions in an elderly venezuelan population.

Authors:  Valentina Mujica; Helen Rivera; Maria Carrero
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2008-05-01

8.  Relationship between the use of full dentures and mucosal alterations among elderly Brazilians.

Authors:  J B Freitas; R S Gomez; M H N G De Abreu; E Ferreira E Ferreira
Journal:  J Oral Rehabil       Date:  2008-05       Impact factor: 3.837

9.  Clinical and histological findings of denture stomatitis as related to intraoral colonization patterns of Candida albicans, salivary flow, and dry mouth.

Authors:  Sandra Altarawneh; Sompop Bencharit; Luisito Mendoza; Alice Curran; David Barrow; Silvana Barros; John Preisser; Zvi G Loewy; Linda Gendreau; Steven Offenbacher
Journal:  J Prosthodont       Date:  2012-10-25       Impact factor: 2.752

10.  Denture stomatitis and its risk indicators in south Brazilian older adults.

Authors:  Camila Mello dos Santos; Juliana Balbinot Hilgert; Dalva Maria Pereira Padilha; Fernando Neves Hugo
Journal:  Gerodontology       Date:  2009-06-22       Impact factor: 2.980

View more
  3 in total

Review 1.  Erythematous and Vascular Oral Mucosal Lesions: A Clinicopathologic Review of Red Entities.

Authors:  Kristin K McNamara; John R Kalmar
Journal:  Head Neck Pathol       Date:  2019-01-29

Review 2.  Non-HPV Papillary Lesions of the Oral Mucosa: Clinical and Histopathologic Features of Reactive and Neoplastic Conditions.

Authors:  Gisele N Mainville
Journal:  Head Neck Pathol       Date:  2019-01-29

Review 3.  Denture Stomatitis Revisited: A Summary of Systematic Reviews in the Past Decade and Two Case Reports of Papillary Hyperplasia of Unusual Locations.

Authors:  Samiha Yousef Sartawi; Shaden Abu-Hammad; Nesreen A Salim; Salah Al-Omoush
Journal:  Int J Dent       Date:  2021-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.